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Abstract
Background: The functional immaturity of T cells contributes to the susceptibility of neonates to
infections and the less severe graft-versus-host disease associated with cord blood (CB)
transplantation. We have previously reported that insulin-like growth factor – I (IGF-I) promotes
the phytohaemagglutinin (PHA)-induced CB T cell maturation and inhibits their apoptosis in
mononuclear cell (MC) culture. We hypothesized that the effects of IGF-I may be mediated by
accessory cells and soluble factors.
Results: This study showed that the kinetics of PHA-induced maturation in purified CD3+ T cell
was delayed compared to that in CBMC. The addition of autologous CD14+ monocytes increased
T cell maturation and potentiated the effect of IGF-I. The addition of IL-6 had no effect on CB T
cell maturation but it reduced PHA-induced apoptosis significantly. We further demonstrated that
the neutralisation of IL-6 in CBMC culture partially abrogated the anti-apoptotic effect of IGF-1 on
T cells. The anti-apoptotic effect of IL-6 was not mediated via the reduction of Fas expression in T
cell subsets.
Conclusion: Our results suggested that the maturation effect of IGF-1 is partially mediated by
monocytes and the anti-apoptotic effect in part via IL-6. Further investigation is needed to explore
the therapeutic use of IGF-I in enhancing neonatal immunity.
Background
Neonates, in particular pre-term babies, have increased
susceptibility to infections. It has been hypothesised that
the functional immaturity of neonates may be the results
of a number of factors, including the immaturity of the
cellular component, the lack of previous exposure to anti-
gens, and the uniqueness of the cytokine environment
[1,2]. There is increasing evidence that the survival of lym-
phocytes during sepsis may improve the disease outcome
of the host [3]. Therefore, cytokines with the potential to
promote the activation of T cells and their survival may
have great clinical application.
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Insulin-like growth factor – I (IGF-I), which is known to
be the mediator for many growth promoting effects of
growth hormone, has also shown to have a direct influ-
ence on the maintenance of normal immune function
[4,5]. It is a lymphopoietic cytokine which has profound
stimulatory effects on lymphopoiesis in vitro [6-8] and in
vivo [4]. Our previous study on cord blood mononuclear
cell (CBMC) culture demonstrated that IGF-I has impor-
tant immunobiological effects on proliferation, IL-6 and
IFN-γ production [9] and increase in telomerase activity
[10]. IGF-1 also promotes maturation and inhibits the
spontaneous and PHA-induced apoptosis of CB T cells
[11]. It reduces the expression of Fas and protects T cells
from Fas ligand induced apoptosis in CBMC culture [11].
These previous studies were based on a mixed population
of cells, in which the direct effect of IGF-1 on T cell and the
roles of non-T cells have not been investigated. The objec-
tive of the current study is to delineate the effect of IGF-I
in purified CD3+ T cell culture and to determine the roles
of accessory cells and soluble factors in mediating the
effects of IGF-I.
CD45, the leukocyte-common antigen, is a family of
transmembrane glycoprotein with tyrosine phosphatase
activity. Various isoforms are formed by the alternative
splicing of three consecutive NH2-terminal exons of the
CD45 transcript and are expressed differentially on hae-
mopoietic cells. The expression of different isoforms is
highly regulated but the detailed mechanisms are still
unknown[12]. CD45RA and CD45RO are two well-stud-
ied isoforms detected on naïve/resting and memory/acti-
vated T lymphocytes respectively. Neonates are
immunologically naive with little exposure to microor-
ganisms and foreign antigens. Therefore, most neonatal T
cells are naive and express CD45RA, whereas both naive
CD45RA+ and mature CD45RO+ T cells are of approxi-
mately equal numbers in adult peripheral blood mono-
nuclear cells [13,14]. Upon the exposure of appropriate in
vitro stimulation, CD45RA+ cells can acquire phenotypic
and functional characteristics of CD45RO+ cells, in partic-
ular the helper cell function and cytokine production [15-
17]. The expression of CD45RA and CD45RO are, how-
ever, not mutually exclusive [18,19] and interconversion
of the CD45 isoform in vivo has been reported [20]. It has
been suggested that the dual positive CD45RA+CD45RO+
cells represent a population of transitional cells which
contain primed T cells, which in the absence of antigenic
stimulation may re-aquire a naïve phenotype [21].
It has been recognised previously that accessory cells, in
particular monocytes, play a crucial role in the regulation
of T lymphocyte differentiation and activation [22-24].
Monocytes express antigen presenting and co-stimulatory
molecules (such as MHC Class II molecules, CD1, CD40,
CD80 and CD86) and release cytokines (such as TNF-α,
IL-1 and IL-6) that act on T lymphocytes. We therefore
extended our experiments to study the role of monocytes
and IL-6 in the maturation of CB T cells in order to deter-
mine the underlying mechanisms mediating the effect of
IGF-I.
IL-6 has been reported to be an anti-apoptotic cytokine
which can prevent T cells apoptosis. However, the reports
are restricted to murine studies [25,26]. Since IGF-I have
also been reported to stimulate the release of cytokines
from monocytes [27] and CBMC [9], we further investi-
gated if IL-6 has a direct anti-apoptotic effect on purified
CD3+ T cells. To confirm the role played by IL-6 in our
previous reports, we neutralised IL-6 in CBMC culture by
monoclonal antibodies. The possible anti-apoptotic
mechanism involving the expression of Fas on different
subsets of T cells was also investigated. This is the first
report which provide evidences that monocytes play a role
in mediating the maturation effect of IGF-I, whereas the
anti-apoptotic effect of IGF-I may be mediated through
the release of IL-6 from accessory cells.
Methods
Cell Preparation
Human umbilical cord blood samples were collected
from the placentae of normal full-term uncomplicated
pregnancy. Informed consent was obtained from the
mothers prior to delivery based on the guidelines
approved by the Institutional Review Board of the Univer-
sity of Hong Kong/Hospital Authority Hong Kong West
Cluster. Ficoll Hypaque density separation (Pharmacia
Fine Chemicals, NJ, USA) was performed to isolate the
low-density mononuclear cells.
CD3+ and CD14+ cells were isolated by positive immu-
nomagnetic separation according to the manufacturer's
recommendation with slight modifications (Miltenyi Bio-
tec GmbH, Bergisch-Gladbach, Germany). High purity of
CD3+ (95.28 ± 0.71%; n = 27) and CD14+ (84.21 ±
1.64%; n = 8) cells were obtained consistently.
Cell Culture
All culture was performed in a serum free, insulin free
medium (DMEM-F12, Sigma Chemical Co. St Louis, MO,
USA) supplemented with 50 i.u./mL penicillin and 50 μg/
mL streptomycin (Gibco BRL, Life Technologies Inc., NY,
USA). IGF-I (100 ng/mL, R&D System, Minneapolis,
USA), PHA (1 μg/mL, Sigma Chemical Co. St Louis, MO,
USA), and IL-6 (1–50 ng/mL, R&D System, Minneapolis,
USA) were added in various combinations as described in
the results. The concentrations of IGF-I and PHA used
have been titrated in previous studies.
CBMC and purified CB CD3+ T cells were cultured at con-
centrations of 1 × 106 and 4 × 105 cells/mL respectively. InBMC Immunology 2008, 9:74 http://www.biomedcentral.com/1471-2172/9/74
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some experiments autologous CB CD14+ monocytes were
added to CD3+ T cells at fixed ratios. The cultures were
incubated at 37°C in 5% CO2 with 100% humidified air
and harvested on Day 3, 6 and 9.
To neutralise the effect of IL-6, CBMC were cultured for 4
days at 1 × 106 cells/mL in DMEM-F12 containing IGF-1
(100 ng/mL) + PHA (1 μg/mL) and 1–20 μg/mL of anti-
IL-6 neutralising antibodies (R&D System, Minneapolis,
USA).
Flow cytometric analysis
The phenotype of cells was analysed by 3-colour flow
cytometry. Briefly, cells were collected at defined time
points and stained with different combinations of FITC,
PE or PC5 conjugated monoclonal antibodies for isotype
control, CD3, CD4, CD8, CD45RA (ALB11), CD45RO
(UCHL1), and CD95 (Beckman Coulter, Immunotech,
Marseille, Cedex, France), and analysed within 24 hours.
Apoptosis in different T cell subsets was detected by
Annexin-V apoptosis kits (Beckman Coulter, Immu-
notech, Marseille, Cedex, France) within 10 minutes of
staining. Using the Beckman Coulter Elite flow cytometer
(Beckman Coulter Electronics, FL, USA), ten thousand
events per sample were collected into listmode files and
analysed by the Prudue University WinMDI software. The
analysis of T lymphocytes in the co-culture system was
achieved by careful setting of flow cytometer parameters
and consistent gating based on the scatter characteristics
of lymphocytes. In this region, over 90% of cells are CD3+
and no CD14+ cells were detected.
Cytokine assay
Cell culture supernatant was collected at defined time
points and the concentration of IL-6 determined by
enzyme-linked immunosorbent assay (ELISA, Quantikit,
R&D System, Minneapolis, USA). The detection limit was
15.6 pg/mL.
Statistical Analysis
All percentages are presented as mean ± standard error of
independent cases unless otherwise stated. The non-para-
metric Wilcoxon signed rank sum test was used to deter-
mine the difference between paired groups; whereas, the
non-parametric Mann-Whitney U statistic test was used
for unpaired groups. The conventional significance level
(α) of 0.05 was used.
Results
IGF-I significantly promoted PHA-induced CD45 isoform 
conversion for CD4+ and CD8+ subsets in CBMC culture
We have previously reported the effect of IGF-I on CD45
isoform conversion in CD3+ cells in CBMC culture [11].
In this study, we further investigated the effect of IGF-I on
CD4+ and CD8+ subsets. In CBMC culture, the majority
of T cells in CBMC are naïve cells
(CD4+CD45RA+CD45RO-: 78.1 ± 1.0%;
CD8+CD45RA+CD45RO-: 89.1 ± 1.9%; n = 8). A small
proportion of cells expressed the intermediate phenotype
(CD4+CD45RA+CD45RO+: 2.8 ± 0.4%;
CD8+CD45RA+CD45RO+: 2.4 ± 0.7%; n = 8) or the
mature phenotype (CD4+CD45RA-CD45RO+: 10.6 ±
1.4%; CD8+CD45RA-CD45RO+: 3.4 ± 1.0%; n = 8).
When stimulated by PHA alone, the
CD4+CD45RA+CD45RO- cells in CBMC culture
decreased gradually from about 80% to 40% from Day 0
to Day 9 (Fig 1a, upper panel, dotted line). There was a
complementary increase in the
CD4+CD45RA+CD45RO+ dual positive population
which reached a maximum level of about 40% on Day 3
and declined to about 20% on Day 6. The proportion of
mature memory cells (CD4+CD45RA-CD45RO+)
remained at about 10% for the first 3 days of activation
before increasing to about 30% by Day 6, and then main-
tained at that level until Day 9.
Similar to the T helper cells, the percentage of
CD8+CD45RA+CD45RO- cytotoxic T cells decreased
sharply after Day 3 of PHA activation, then maintained at
about 60% through to Day 9 (Fig 1a, lower panel, dotted
line). The CD8+CD45RA+CD45RO+ double-positive
cells was highest on Day 3 (~30%), and then maintained
at rather low level of ~10% from Day 6 to Day 9. The
CD45RO single-positive CD8+ cells (CD8+CD45RA-
CD45RO+) increased gradually over the 9 days of culture.
The addition of IGF-I to the CBMC did not change the
general kinetic of CD45RA to CD45RO conversion but
significantly promoted the decline in the proportion of
naïve T cells and the increase in memory/mature pheno-
type (Fig 1a, solid lines). The effects of IGF-I on CD4+ and
CD8+ cells in CBMC cultures were similar. To consolidate
our observation, we compared the percentages of naïve
and mature T helper and cytotoxic T cells in Day 6 culture
with PHA ± IGF-I (Fig 2a). IGF-I significantly decreased
the percentages of CD45RA+ cells (p < 0.001; n = 8) and
increased the percentages of CD45RO+ cells (p < 0.001; n
= 8).
The kinetics of PHA-induced CD45 isoform conversion in 
purified CD3+ T cell culture was different from that in 
CBMC culture
Immunomagnetic separation yield highly purified CD3+
population in which a high majority of the CB T cells are
naïve, bearing the CD45RA+ phenotype
(CD4+CD45RA+CD45RO-: 89.8 ± 2.5%;
CD8+CD45RA+CD45RO-: 94.8 ± 1.6%; n = 8). A very
small proportion of the cells co-expressed both CD45 iso-
forms (CD4+CD45RA+CD45RO+: 2.5 ± 3.6%;BMC Immunology 2008, 9:74 http://www.biomedcentral.com/1471-2172/9/74
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The kinetics of CD45 isoform changes for CD4+ T helper cells and CD8+ cytotoxic T cells in (a) CBMC culture; and, (b) puri- fied CD3+ T cell culture Figure 1
The kinetics of CD45 isoform changes for CD4+ T helper cells and CD8+ cytotoxic T cells in (a) CBMC culture; 
and, (b) purified CD3+ T cell culture. CBMC (a) or CD3+ T cells (b) were incubated for different period with PHA (1 μg/
ml ----m----) alone or PHA + IGF-I (100 ng/ml —l—). CD45 isoform expression was determined by three-colour flow cytom-
etry. The kinetics of transition from naïve to mature/memory phenotype in CD4+ and CD8+ cells were similar. In CBMC, IGF-
I promoted the PHA-induced maturation of CD45 isoforms. In CD3+ T cells, the maturation process was delayed and IGF-I 
only slightly promoted the PHA-induced maturation of CD45 isoforms. Results shown are representatives of 5 similar inde-
pendent cases in each group.
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Effects of IGF-I on PHA-induced changes in CD45 isoform expression on CD4+ T helper cells and CD8+ cytotoxic T cells in  (a) CBMC culture; and, (b) purified CD3+ T cell culture Figure 2
Effects of IGF-I on PHA-induced changes in CD45 isoform expression on CD4+ T helper cells and CD8+ cyto-
toxic T cells in (a) CBMC culture; and, (b) purified CD3+ T cell culture. CBMC (a) or CD3+ T cells (b) were incu-
bated with PHA (1 μg/ml) ± IGF-I (100 ng/ml) for 6 days. IGF-I significantly promoted the PHA-induced down-regulation of 
naïve T cells (CD45RA+CD45RO-) and up-regulation of mature T cells (CD45RA-CD45RO+). Results shown are from 8 and 
14 independent cases of CBMC and CD3+ T cells respectively.
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CD8+CD45RA+CD45RO+: 2.3 ± 1.1%; n = 8) and only a
minority of cells expressed the CD45RO+ memory/
mature phenotype (CD4+CD45RA-CD45RO+: 7.7 ±
3.8%; CD8+D45RA-CD45RO+: 3.0 ± 0.9%; n = 8).
When the purified CD3+ T cells were cultured in serum
free medium or IGF-I alone, there was no spontaneous
conversion of CD45 isoforms and too few cells survive
after day 6 for phenotypic analysis (data not shown). Sim-
ilar to the observation in CBMC, PHA alone induced the
conversion of CD45RA+ cells into CD45RO+ cells in the
CD3+ cell culture (Fig 1b, dotted lines). However, there
was a delay in the conversion of naïve cells to the dual
positive cells and consequently the delay in the matura-
tion of cells into the CD45RO+ phenotype. The percent-
age of CD45RA+CD45RO+ cells reached maximum on or
after Day 6 and the percentage of CD45RA-CD45RO+
cells was maximum on Day 9 in CD3+ cell culture.
The kinetics of CD45 isoform switching in culture with
PHA+IGF-I was very similar to that observed in CD3+ T
cells cultured with PHA alone (Fig 1b). IGF-I only pro-
moted a slight increase (<10%) in T cell maturation (Fig
1b, solid lines). Summarising data from 14 experiments
(Figure 2b), we confirmed that IGF-I significantly pro-
moted PHA-induced T cell maturation in CD3+ T cell cul-
ture (Fig 2b). However, the effect of IGF-I in purified
CD3+ T cell culture was weaker than that observed in
CBMC culture suggesting that factors present in the CBMC
culture but absent in CD3+ T cells culture may be critical
mediators of the effect of IGF-I.
Monocytes potentiated the effect of IGF-I on PHA-induced 
CD45 isoform conversion
To determine if monocytes play a role in the conversion of
CD45 isoform, we added autologous CD14+ monocytes
back to the purified CD3+ T cell cultures at monocytes to
T cells ratios of 1:4 based on our analysis of the mean
CD14+:CD3+ ratio in CBMC (1:3.8 ± 2.5; n = 26). The
effects of monocytes and IGF-I on PHA-induced CD45
isoform conversion is summarised in Figure 3. Similar to
previous experiments, the addition of IGF-I significantly
promoted CD4+ cell maturation (Figure 3a, 21.3% vs
26.9% in PHA vs PHA+IGF-I respectively; p = 0.009; n =
7). The addition of monocytes alone increased the per-
centage of mature cells but did not reach statistical signif-
icance (21.3% vs 25.3% in PHA vs PHA+monocyte
respectively; p = 0.063). In the presence of both IGF-I and
monocytes, the CD4+CD45RA-CD45RO+ cells reached
31.6%. This is significantly higher than PHA alone (p =
0.005) or PHA+monocyte (p = 0.008) but not PHA+IGF-I
(p = 0.0866). There was a trend of increased maturation
and it is due to sample variation that the difference did
not reach statistical significance.
In CD8+ cells (Figure 3b), the addition of IGF-I promoted
maturation but the increase did not reach statistical signif-
icance (15.6% vs 10.3% in PHA vs PHA+IGF-I respec-
tively; p = 0.079; n = 7). The addition of monocytes alone
significantly increased the percentage of mature cells
(15.6% vs 19.2% in PHA vs PHA+monocyte respectively;
p = 0.015). In the presence of both IGF-I and monocytes,
the CD4+CD45RA-CD45RO+ cells reached 18.9%. This is
significantly higher than PHA alone (p = 0.044) but not
significantly different from PHA+IGF-I (p = 0.2403) and
PHA+monocytes (p = 0.8186).
IL-6 did not modulate PHA-induced CD45 isoform 
conversion in CD3+ T cell culture
In our previous report, we have demonstrated that IGF-I
increases the protein production and mRNA expression of
IL-6 in PHA-stimulated CBMC culture [9]. In this study,
we analysed the concentrations of IL-6 in cell supernatant
collected from Day 3 CB CD3+ T cell cultures (Figure 4).
The level of IL-6 (range 1 – 120 pg/mL, n = 7) was much
lower than that observed previously in CBMC (range: 600
pg/mL – 4000 pg/mL). IGF-1 alone stimulated a slight but
significant increase in IL-6 (medium = 1.47 ± 0.26 pg/mL
vs IGF-1 = 3.27 ± 0.64 pg/mL, p = 0.04). PHA alone also
stimulated IL-6 production but due to sample variation,
the changes did not reach statistical significance (PHA =
10.76 ± 5.02 pg/mL, p = 0.22). IGF-1 induced a significant
increase in PHA-induced IL-6 production (PHA+IGF-1 =
55.39 ± 11.71 pg/mL; p = 0.02). The addition of higher
concentration of PHA (10 μg/mL) did not increase the
production of IL-6 in T cell culture (data not shown). We
determined the role of IL-6 in T cell maturation by adding
titrated dose of IL-6 (1–50 ng/mL) to PHA-stimulated
CD3+ T cells culture. The addition of IL-6 within this
range did not affect the maturation of T helper cells/cyto-
toxic T cells in PHA-stimulated CD3+ T cell culture (data
not shown, n = 3, p > 0.05).
IL-6 was more efficient than IGF-I in inhibiting PHA-
induced apoptosis in CD3+ T cell culture
We further investigated the effects of IGF-I and IL-6 on
apoptosis in the CD4+ and CD8+ subsets in the purified
CD3+ cell culture. In cultures with medium or IGF-1
alone, too few cells survived on Day 4 for apoptosis anal-
ysis (data not shown). Similar to the observation in
CBMC, PHA alone induced mainly early apoptosis of the
T cell culture (AV+PI- % = 70.8 ± 3.8%; n = 9). Only a
minor proportion of cells were in late apoptosis (AV+PI+
% = 5.2 ± 1.0%; n = 9). IGF-1 induced similar level of
apoptosis in the whole population (AV+PI- % = 69.1 ±
5.1%; p = 0.57; AV+PI+ % = 3.8 ± 0.5%; p = 0.31; n = 9).
Since majority of the cells are PI-, we omitted the PI stain-
ing and determined the percentage of AV+ cells in each T
cell subset as the index of apoptosis using 3 colour flowBMC Immunology 2008, 9:74 http://www.biomedcentral.com/1471-2172/9/74
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cytometry (Figure 5a). The addition of IGF-1 caused a
slight reduction of apoptosis the reduction only reached
statistical significance in the CD4+CD45RO+ and
CD8+CD45RO+ subsets (both p = 0.002; n = 9).
Since the observed anti-apoptotic effect of IGF-1 in the
purified CD3+ T cells culture was much lower than that
previously observed in mixed population of CBMC, we
studied the effect of IL-6 on PHA-induced apoptosis in
CD3+ T cells. In our preliminary experiments, IL-6 (1–50
ng/mL) significantly inhibited PHA-induced apoptosis in
a dose dependant manner reaching maximum reduction
at 10 ng/mL (data not shown). IL-6 (10 ng/mL) signifi-
cantly lowered the percentage of early apoptotic cells in
PHA-induced T cells from 63.8 ± 5.4% to 18.5 ± 2.2% (p
= 0.029; n = 4). There was very low percentages of late
apoptotic cells (PHA = 2.7 ± 0.8% and PHA+IL-6 = 1.6 ±
0.3%). As shown in Figure 5b, the percentages of AV+ cells
in all the T cell subsets were reduced by about 40% in all
T cell subsets and there was no preferential protection for
naïve versus memory T helper cells nor cytotoxic T cells.
Neutralisation of IL-6 in CBMC culture abrogates the anti-
apoptotic effect of IGF-1
To confirm the role played by IL-6, we neutralised IL-6 in
mixed CBMC culture by anti-IL-6 antibodies (1–20 μg/
Effects of monocytes in potentiating the effects of IGF-I on PHA-induced changes in CD45 isoform expression in purified  CD3+ T cell culture Figure 3
Effects of monocytes in potentiating the effects of IGF-I on PHA-induced changes in CD45 isoform expression 
in purified CD3+ T cell culture. CD3+ T cells were incubated with PHA (1 μg/ml) alone, PHA + IGF-I (100 ng/ml), PHA + 
autologous CD14+ monocytes (monocytes: T cells ratio = 1:4), or PHA + IGF-I + monocytes for 6 days. The addition of 
monocytes promoted CD4+ and CD8+ T cells maturation and the effect was further increased in the presence of IGF-I. 
Results shown are from 7 independent cases of CD3+ T cells respectively.
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mL) and determined the proportion of apoptotic cells by
flow cytometry. Neutralisation of IL-6 by 1–20 μg/mL of
anti IL-6 antibodies resulted in similar increase in the per-
centages of apoptotic cells in CBMC culture (data not
shown). As low as 1 μg/mL of anti-IL-6 can significantly
increase the percentage of early apoptotic cells (PHA+IGF-
1 = 48.6 ± 5.8% and PHA+IGF-1+anti-IL-6 = 53.7 ± 6.5%;
p = 0.0156; n = 7) but not the late apoptotic cells
(PHA+IGF-1 = 1.5 ± 0.2% and PHA+IGF-1+anti-IL-6 = 1.4
± 0.2%; p = 0.3125; n = 7). The changes was particularly
significant in the CD4+CD45RA+ and CD8+CD45RO+ T
cells subsets (both p < 0.001; n = 7; Figure 6).
The anti-apoptotic effect of IL-6 on T cell subsets in CD3+ 
culture was not mediated by reduction in Fas expression
Increasing number of pathways involving various mole-
cules have been reported for programmed cell death [28].
We have previously reported that IGF-1 down-regulates
the expression of Fas on T cells in CBMC culture and pro-
tects cells from Fas ligand induced apoptosis [11]. In this
study, we also analysed the effects of IGF-1 and IL-6 on the
expression of Fas on PHA stimulated CD3+ T cells. IGF-1
slightly reduced the expression of Fas on PHA stimulated
T cells (Figure 7) but the reduction did not reach statistical
significance (p = 0.55, 0.55, 0.84, and 0.55 for
CD4+CD45RA+, CD4+CD45RO+, CD8+CD45RA+, and
CD8+CD45RO+ respectively; n = 5). The addition of IL-6
induced a slight but statistical insignificant increase in Fas
expression in all T cell subsets (p = 0.15, 0.31, 0.31, and
0.69 for CD4+CD45RA+, CD4+CD45RO+,
CD8+CD45RA+, and CD8+CD45RO+ respectively; n =
5).
Discussion
The functional immaturity of T cells in neonates has been
considered as one of the major contributing factors for the
susceptibility of neonates to infections (Kovarik et al,
1998) as well as less severe graft-versus-host disease
(GvHD) associated with cord blood stem cell transplant
[29]. Probably as a result of antigen exposure, there is an
age-related decrease in "virgin, non-antigen primed, naïve
CD45RA+ T cells" and increase in "mature, activated,
memory CD45RO+ T cells" [30-33]. The expression of
CD45 isoforms is also regulated by mitogenic and anti-
genic activation. When stimulated with mitogens such as
PHA or Con A in vitro, CD45RA+ T cells lose CD45RA
expression and gain CD45RO expression [34-36].
Cytokines that can promote the maturation of T cells
would have a high potential for clinical application in the
management of infection in neonates.
IGF-I has been reported to have profound positive effects
on immune function [7] and most recently IGF-I has
shown to increase survival in a murine sepsis model [37].
We have previously reported the positive effects of IGF-I
on PHA-stimulated CBMC in terms of cytokine produc-
tion [9], proliferation [10], and survival [11]. In this
study, we further demonstrated that IGF-I can signifi-
cantly promote the PHA-induced cord blood T helper cell
and cytotoxic T cell maturation in CBMC but less effi-
ciently in the purified CD3+ T cell culture in which acces-
sory cells are absent (Figure 1).
Similar to a previous report on CD45 isoform conversion
of CB CD4+ cells [38], our results demonstrated rapid
decrease of CD45RA+CD45RO- cells with reciprocal
increase in CD45RA-CD45RO+ cells in both the CD4+
and CD8+ subsets when CBMC or purified CD3+ cells
were stimulated by PHA with or without IGF-I. As sup-
ported by the kinetics of expression, especially the pres-
ence of the transitional dual positive cells, the observed
decline in naïve cells and corresponding increase in
mature cells represent the conversion of CD45 isoforms
rather than the preferential expansion/survival of mature
cells or the selective elimination of naïve cells.
The PHA-induced in vitro CB T cells maturation was
delayed in the absence of accessory cells. This delay in
maturation might have led to delayed expression of IGF-I
receptors, and hence, IGF-I only slightly promoted T cell
maturation. Previous studies on the expression of IGF-I
receptors on activated T cells were limited to adult cells
and the results have been controversial. Using iodopep-
tide comparative binding studies, an increase in IGF-I
Effect of IGF-1 on IL-6 production in CB CD3+ T cell culture Figure 4
Effect of IGF-1 on IL-6 production in CB CD3+ T cell 
culture. The level of IL-6 detected in the purified T cell cul-
ture was much lower than that observed previously in 
CBMC. IGF-1 alone induced a slight but significant increase in 
IL-6 (n = 7; * p = 0.04). PHA alone did not induce IL-6 pro-
duction (p = 0.44). IGF-1 induced a significant increase in 
PHA-induced IL-6 production. Results shown are mean ± 
SEM of 7 independent cases (* p = 0.02).BMC Immunology 2008, 9:74 http://www.biomedcentral.com/1471-2172/9/74
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Effects of IGF-1 and IL-6 on PHA-induced apoptosis in purified CB CD3+ T cell culture Figure 5
Effects of IGF-1 and IL-6 on PHA-induced apoptosis in purified CB CD3+ T cell culture. CB CD3+ T cells were 
cultured with (a) PHA (1 μg/mL) ± IGF-1 (100 ng/mL) or (b) PHA (1 μg/mL) ± IL-6 (10 ng/mL) for 4 days. Both IGF-1 and IL-6 
significantly inhibited PHA-induced apoptosis in T cell subsets. Results shown are mean ± SEM of 9 and 4 independent cases of 
CD3+ T cells respectively (* p < 0.05).
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receptors expression on activated T cells has been reported
[39]. Different IGF-I receptor expression on activated T
cells (CD4+CD45RA+ > CD8+CD45RA+ >
CD8+CD45RO+ > CD4+CD45RO+) has also been
reported [40]. On the contrary, Schillaci et al [41]
reported a rapid decline in IGF-I receptors on both CD4+
and CD8+ cells after activation. Further experiments are
therefore needed to determine if the effect of IGF-I in pro-
moting the change in CD45RA to CD45RO isoforms in
neonatal cells is due to differential expression of IGF-I
receptors in these subpopulations.
Due to the limitation of two colour flow cytometry or the
combination of antibodies in the past, some reports have
considered the expression of CD45RA and CD45RO to be
mutually exclusive [13,14]. Only few reports have
reported the presence of dual positive
CD45RA+CD45RO+ in adult peripheral blood. These
cells were proposed to be representing activated lym-
phocytes after viral infection [42] or primed transitional
cells with characteristic antigenic and cytokine expression
[43]. In a study on neonates with documented sepsis, up
regulation of CD45RA+RO+ cells on CD4+ cells was
detected early in the infection [44]. In our study, we have
consistently detected a CD45RA+CD45RO+ population
in the activated culture. The different kinetics of dual pos-
itive cells in CBMC and purified T cell culture suggested
that some factors which promote a rapid but transient
increase of dual positive cells in Day 3 CBMC was missing
in purified T cell culture (Figure 1). This hypothesis was
subsequently confirmed by the co-culture experiments, in
which the addition of monocytes to T cells at 1:4 ratio
restored the kinetics of dual positive T cells (data not
shown). Further research on the cellular function of dual
positive cells and the molecules regulating T cell matura-
tion is important because these cells may be potential can-
didates for ex vivo expansion of T cells for autologous
immunotherapy. The possibility of interconversion of
CD45RA+ and CD45RO+ cells also deserves further inves-
tigation which may have implication in the strategy of
limiting GvHD in haemopoietic stem cell transplant.
In previous study of T cell proliferation, it has been sug-
gested that complete activation of T cells requires at least
two signals: (1) by antigen-specific T cell receptor; and,
(2) by antigen presenting cells and/or cytokines produced
by antigen presenting cells [45]. Some reports also
emphasised on an absolute requirement of accessory cells
for T cell proliferation [46-48]. The ability of different sub-
populations of adult blood mononuclear cells to serve as
accessory cells has been studied previously. Halvorsen et
al  [49] have reported that the removal of monocytes
decreased the ability of non T cells to serve as accessory
cells for both CD4+ and CD8+ cells stimulated by PHA.
The need of monocyte to T cell contact has also been
established by separating the cells by a semi-permeable
membrane which allows the diffusion of macromolecules
[50]. Novel pathway of monocyte dependent regulation
of T cells has been reported and the relationship between
monocytes and T cells is complicated because the mole-
cules expressed on monocytes can be stimulatory, such as
Effect of neutralising anti-IL-6 antibodies on IGF-1 stimulated  PHA-induced apoptosis in CBMC culture Figure 6
Effect of neutralising anti-IL-6 antibodies on IGF-1 
stimulated PHA-induced apoptosis in CBMC culture. 
Neutralising anti-IL-6 antibodies (1 μg/mL) were added to 
CBMC cultured in serum free medium with PHA (1 μg/mL) + 
IGF-1 (100 ng/mL). Anti-IL-6 antibodies abrogated the anti-
apoptotic effects of IGF-1. Results shown are mean ± SEM of 
7 independent cases (* p < 0.05).
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Effect of IGF-1 and IL-6 on PHA-induced CD95 (Fas) expres- sion on T cell subsets in CB CD3+ T cell culture Figure 7
Effect of IGF-1 and IL-6 on PHA-induced CD95 (Fas) 
expression on T cell subsets in CB CD3+ T cell cul-
ture. CB CD3+ T cells were cultured with PHA (1 μg/mL) ± 
IGF-1 (100 ng/mL) or IL-6 (10 ng/mL) for 4 days and the 
expression of CD95 (Fas) on T cell subsets determined by 3 
colour flow cytometry. IGF-1 slightly downregulated CD95 
expression on T cell subsets while IL-6 slightly upregulated 
CD95 expression on T cell subsets. Results shown are mean 
± SEM of 5 independent cases (* p < 0.05).
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CD1a [51], or inhibitory, such as CD98 [52]. In this study,
purified autologous CD14+ monocytes added to purifed
CD3+ T cells promoted the PHA-induced T cell matura-
tion and further increased the percentage of CD45RA-
CD45RO+ cells in Day 6 culture. The addition of mono-
cytes to PHA-stimulated CD3+ cells in the presence of
IGF-I, significantly increased the percentage of CD45RA-
CD45RO+ cells. We, therefore, suggest that IGF-I acts on
monocytes which in turn promotes the PHA-induced
CD45 isoform conversion in CB T cells.
The ratio of monocyte to T cells in the co-culture may also
affect the PHA- induced CD45 isoform conversion. In this
study, we have mixed the cells at monocyte to T cell ratio
of 1:4 based on the ratio observed in freshly isolated
CBMC. In other studies, the addition of only 2–4% mito-
mycin C treated plastic adherent CD14+ monocytes was
shown to be effective in inducing activation of T cells
[38,53]. On the other hand, Wesch et al [54] have
reported significant cell death in a 1:1 co-culture of T cells
and monocytes in the presence of PMA or PHA. The CD4+
and CD8+ subsets were equally susceptible to the mono-
cyte dependent cell death (MDCD) but the effect of differ-
ent mitogens is regulated by different mechanisms. We
have not studied the effect of monocytes on T cell death
but the observation under light microscopy and the scat-
ter characteristics determined by flow cytometry did not
show obvious difference in cultures with and without
monocytes.
The relationship between cytokine production and cellu-
lar activation in the co-culture system is multidirectional.
When stimulated, cord blood cells can produce IL-6, IL-2,
IFN-γ, TNF-a and IL-10 but little IL-4 and IL-5 [9,55,56].
Freshly purified CD4+CD45RA+ cells, however, did not
produce IL-2, IL-4 and IFN-γ upon primary stimulation
(PHA or anti-CD2) but secrete IL-2 and IFN-γ after sec-
ondary stimulation by accessory cells [38,55]. IFN-γ can in
turn stimulate HLA-DR expression on monocytes further
enhancing their accessory function [57]. It is therefore
important to study the cytokines released in the co-culture
of monocytes and T cells in our system for the identifica-
tion of potential candidates responsible for the observed
induction in T cell maturation.
It has been reported that IGF-I stimulates the release of
cytokine from monocytes [27] and it has been shown to
stimulate the release of significantly increased amounts of
IL-6 in PHA-induced CBMC culture in our previous report
[9]. IL-6 is produced by a variety of haemopoietic cells and
the cross-linking of Fc receptors on monocytes and trig-
gers IL-6 production [58]. IL-6 provides accessory signals
for T cell activation, and antisera to IL-6 completely neu-
tralised the helper effect of monocyte supernatant for
PHA-induced human T cell activation and prolifera-
tion[59,60]. In this study, IGF-I only stimulated a very low
level of IL-6 in the purified CD3+ T cells suggesting that
the major source of IL-6 in CBMC culture is from non-T
cells. Interestingly, the addition of IL-6 (in the range of 1
– 50 ng/mL) did not alter the kinetics nor the extent of
PHA-induced CB T cell maturation. This is suggestive that
CB T cell maturation may require the presence of other
cytokines and/or cell-cell interaction. Future experiments
using transwell to separate the T cells and monocytes in
the co-culture can determine if the effect of monocyte is
contact dependent.
Activation of T cells by PHA leads to a series of events
including maturation, proliferation and activation
induced apoptosis. We have previously reported the anti-
apoptotic effect of IGF-I and demonstrated the downregu-
lation of Fas expression on PHA-induced T cells in CBMC.
In the purified CB CD3+ T cells culture, the anti-apoptotic
effect of IGF-1 is weaker than that observed in the CBMC
culture. It is evident that factors that are present in CBMC
culture but absent in the purified T cell culture are respon-
sible in mediating the anti-apoptotic effect of IGF-1. We
showed that IL-6, a factor that is upregulated by IGF-1 in
CBMC culture [9], strongly inhibited PHA-induced apop-
tosis in purified T cell culture (Figure 5). The concentra-
tion of IL-6 used (10 ng/mL) is comparable to the
maximum concentration assayed in the CBMC culture (~5
ng/mL).
The anti-apoptotic role played by IL-6 was further con-
firmed by the neutralising experiments. As shown in Fig-
ure 6, the neutralisation of IL-6 in the PHA + IGF-I CBMC
culture significantly increased the percentage of apoptotic
cells. Since the anti-apoptotic effect of IGF-I was not com-
pletely neutralised by anti-IL-6 antibodies, the result sug-
gested that other cellular or molecular factors in the mixed
CBMC culture may be mediating the effects of IGF-I. The
addition of other neutralising antibodies may allow us to
identify these factors.
It has been reported that IL-6 prevents the TCR/CD3 acti-
vation induced cell death by decreasing the expression of
Fas and FasL expression [61]. We, therefore, determined
whether the anti-apoptotic effect of IL-6 is mediated
through the downregulation of Fas expression in the
CD3+ T cell culture. To our surprise, IL-6 slightly upregu-
lated Fas expression (Figure 7) but the induction did not
reach statistical significance. This result suggested that (1)
the anti-apoptotic effect of IL-6 in purified CD3+ T cell
culture is not Fas dependent, and (2) cell-cell interaction
and other cytokines upregulated by IGF-1 may be respon-
sible for the down regulation of CD95 (Fas) previously
observed in the CBMC culture. In addition, IL-6 has also
been reported to protect cells from apoptosis via the bcl-
2/p53 pathway [62]. Therefore other intracellular signal-BMC Immunology 2008, 9:74 http://www.biomedcentral.com/1471-2172/9/74
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ling pathway and the expression of IL-6 receptor on CB T
cell subsets also worth further investigation.
Conclusion
In this study, we have described the role of accessory cells
and IL-6 in mediating the effect of IGF-I on PHA-induced
CB T cells maturation and apoptosis. Knowledge on the
mechanism by which monocytes play their accessory role
may be used to develop new protocols for therapeutic
manipulation of cells. With the high frequency of neona-
tal sepsis and increased use of CB for haemopoietic recon-
stitution, a better understanding of CB T cell physiology
and the potential of some cytokines in promoting the sur-
vival and activation of T cells will help to lower the mor-
tality caused by infection in infants [63-66]. The
knowledge will also give insights into designing ex-vivo
expansion of cells for immunotherapy and graft engineer-
ing.
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